Back to search results

VERABAND™ for Chronic Low-back Pain

This study is looking at how satisfied clinicians (doctors, nurses, etc.) are with a new wearable device called VERABAND™. This device is designed to track activity in people with chronic low-back pain (pain lasting a long time). Researchers want to see if clinicians find the VERABAND™ easy to use and if they would want to use it in their practice. You could be eligible if you are between 18 and 85 years old, can walk, and have chronic low-back pain. The study will measure clinician satisfaction and the likelihood of them adopting the VERABAND™ after about 7 weeks. The current recruitment status is unclear.

Study design
This is an interventional study involving 340 patients with chronic low-back pain and 20 clinicians across multiple pain clinics.
What's involved
If you participate, you will receive a VERABAND™ activity monitor at an initial clinic visit and will be tracked as you begin a new pain treatment. Your clinician will receive reports from the VERABAND™ before your follow-up visits.
Compensation
Not stated in the trial record.
Follow-up
Clinician satisfaction will be measured at approximately 7 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06080464

Clinician Satisfaction With the VERABAND™

Recruiting
NAAges 18–85InterventionalHealth services
University of Michigan
~360 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:VERABAND information

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Measure clinician satisfaction of the usability of the VERABAND™ using the System Usability Scale (SUS)
Measured over approximately 7 weeks
+1 more outcome measured

Conditions

Chronic Low-back Pain

Explore related trials

Chronic low back pain

Where it's being run

3 sites across 3 states
California1
Kansas1
Michigan1

Study leadership

  • Daniel Whibley, PhD · PRINCIPAL_INVESTIGATOR · University of Michigan

Who to contact

Kristi Pickup, MSW
[email protected]
734-764-4072
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ambulatory
Diagnosis of chronic low back pain (cLBP) according to the criteria of National Institute of Health (NIH) Task Force on Research Standards for cLBP
Answering 'Yes' to the question: Does your low back pain interfere with your mobility?
Starting any new non-surgical treatment or combination of treatments for cLBP as part of their normal ongoing care, including medications; physical therapy/exercise; integrated therapies (e.g., massage, acupuncture, yoga); cognitive- behavioral therapy; and/or interventional procedures (e.g., epidural steroid or facet joint injections)
Willingness to wear a VERABAND™ continuously until their next clinic visit and return used devices in the mail.

Exclusion

Clinical findings suggesting the presence of ongoing systemic disease, including fever, weight loss, initiation of pain following major trauma, immunosuppression, intravenous drug use, recent bacterial infection, severe or persistent sensory or motor involvement of bowel, bladder, or lower extremity; or any condition that would greatly limit physical activity not due to pain.
Inability to speak and write English.
Visual or hearing difficulties that would preclude participation.
Individuals receiving disability or compensation or involved in litigation.
Scheduled surgery before follow-up.

What this trial measures

  • Measure clinician satisfaction of the usability of the VERABAND™ using the System Usability Scale (SUS)approximately 7 weeks

    The SUS is comprised of 10 statements: Each statement is accompanied by a five-point scale Likert response option. The SUS ranges from 10-50 and the higher scores indicate higher clinician satisfaction with usability.

  • Measure the likelihood of clinical adoption of the VERABAND™ using Item 1 of the System Usability Scale (SUS)approximately 7 weeks

    The SUS item is a five-point scale Likert response ranging from 1-5. Higher scores indicate increase likelihood of clinical adoption of the VERABAND™